Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04667585	Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx	active not recruiting	N/A	120	Duke UniversityOTHER	1	Jun 12, 2026	clinicaltrials
NCT04713449	Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial	active not recruiting	N/A	643	Rutgers, The State University of New JerseyOTHER	1	Feb 23, 2026	clinicaltrials